Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance Imaging.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
01 01 2020
Historique:
received: 24 12 2018
accepted: 18 07 2019
pubmed: 2 10 2019
medline: 25 8 2020
entrez: 2 10 2019
Statut: ppublish

Résumé

In diffuse WHO grade II gliomas (LGG), the extent of resection (EOR) required to achieve significant survival benefits remains elusive. To evaluate the association of residual volume (RV) and EOR with progression-free survival (PFS) or overall survival (OS) in LGG in a retrospective, multicenter series by the German study group of intraoperative MRI (GeSGIM). Consecutive cases were retrospectively assessed from 5 centers. Tumors were volumetrically quantified before and after surgery, and clinical data were analyzed, including IDH mutations and neurologic deficits. Kaplan-Meier estimates, accelerated failure time models (AFT), and multivariate Cox regression models were calculated to identify determinants of survival. A total of 140 cases were analyzed. Gross total resection (GTR) was associated with significantly longer PFS compared to any incomplete resection (P = .009). A significant survival disadvantage was evident even for small (>0-5 ml) residuals and increased for moderate (>5-20 ml) and large remnants (>20 ml) P = .001). Accordingly, PFS increased continuously for 20% incremental steps of EOR (P < .001). AFT models supported the notion of a continuous association of RV and EOR with PFS. Multivariate Cox regression models confirmed RV (P = .01) and EOR (P = .005) as continuous prognosticators of PFS. Univariate analysis showed significant associations of RV and EOR with OS. Our data support the hypothesis of a continuous relationship of RV and EOR with survival for LGG with superiority seen for GTR. Hence, GTR should be achieved whenever safely feasible, and resections should be maximized whenever tumor has to be left behind to spare function.

Sections du résumé

BACKGROUND
In diffuse WHO grade II gliomas (LGG), the extent of resection (EOR) required to achieve significant survival benefits remains elusive.
OBJECTIVE
To evaluate the association of residual volume (RV) and EOR with progression-free survival (PFS) or overall survival (OS) in LGG in a retrospective, multicenter series by the German study group of intraoperative MRI (GeSGIM).
METHODS
Consecutive cases were retrospectively assessed from 5 centers. Tumors were volumetrically quantified before and after surgery, and clinical data were analyzed, including IDH mutations and neurologic deficits. Kaplan-Meier estimates, accelerated failure time models (AFT), and multivariate Cox regression models were calculated to identify determinants of survival.
RESULTS
A total of 140 cases were analyzed. Gross total resection (GTR) was associated with significantly longer PFS compared to any incomplete resection (P = .009). A significant survival disadvantage was evident even for small (>0-5 ml) residuals and increased for moderate (>5-20 ml) and large remnants (>20 ml) P = .001). Accordingly, PFS increased continuously for 20% incremental steps of EOR (P < .001). AFT models supported the notion of a continuous association of RV and EOR with PFS. Multivariate Cox regression models confirmed RV (P = .01) and EOR (P = .005) as continuous prognosticators of PFS. Univariate analysis showed significant associations of RV and EOR with OS.
CONCLUSION
Our data support the hypothesis of a continuous relationship of RV and EOR with survival for LGG with superiority seen for GTR. Hence, GTR should be achieved whenever safely feasible, and resections should be maximized whenever tumor has to be left behind to spare function.

Identifiants

pubmed: 31574147
pii: 5580032
doi: 10.1093/neuros/nyz397
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

E64-E74

Informations de copyright

Copyright © 2019 by the Congress of Neurological Surgeons.

Auteurs

Moritz Scherer (M)

Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany.

Hajrulla Ahmeti (H)

Department of Neurosurgery, University of Schleswig-Holstein, Kiel, Germany.

Constantin Roder (C)

Department of Neurosurgery, University of Tübingen, Tübingen, Germany.

Florian Gessler (F)

Department of Neurosurgery, University of Frankfurt, Frankfurt, Germany.

Christine Jungk (C)

Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany.

Andrej Pala (A)

Department of Neurosurgery, University of Ulm, Günzburg, Germany.

Benjamin Mayer (B)

Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.

Christian Senft (C)

Department of Neurosurgery, University of Frankfurt, Frankfurt, Germany.

Marcos Tatagiba (M)

Department of Neurosurgery, University of Tübingen, Tübingen, Germany.

Michael Synowitz (M)

Department of Neurosurgery, University of Schleswig-Holstein, Kiel, Germany.

Christian Rainer Wirtz (CR)

Department of Neurosurgery, University of Ulm, Günzburg, Germany.

Andreas W Unterberg (AW)

Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany.

Jan Coburger (J)

Department of Neurosurgery, University of Ulm, Günzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH